Superdisintegrants Market Share, Size, Trends, Industry Analysis Report, By Product (Modified Starch, Modified Cellulose, Crospovidone, Ion Exchange Resin); By Formulation; By Therapeutic Area; By Region; Segment Forecast, 2024-2032
- Published Date:Jan-2024
- Pages: 114
- Format: PDF
- Report ID: PM3382
- Base Year: 2023
- Historical Data: 2019-2022
Report Outlook
The global superdisintegrants market was valued at USD 439.25 million in 2023 and is expected to grow at a CAGR of 7.3% during the forecast period. The pharmaceutical industry is constantly expanding, and there is a need for innovative drug delivery systems. Superdisintegrants improve the bioavailability and efficacy of drugs, making them an essential component in drug formulation. The pharmaceutical industry handles the creation, production, and distribution of medicines.
To Understand More About this Research: Request a Free Sample Report
Innovations in the super disintegrants market are driving the growth and demand for the market. For instance, Natural mucilage is used in drug delivery systems (DDS) for several purposes, including directly or indirectly controlling the pace and volume of drug release under particular conditions. Due to its easier accessibility, lower cost, and chemical inertness, natural mucilage has advantages over synthetic mucilage.
Orally disintegrating tablets (ODTs) have become much more popular over the past ten years due to their major impact on patient compliance. Especially for those who have trouble swallowing, a sizable portion prefers pills that dissolve when taken orally. This will further fuel the demand and growth of the market in the upcoming years. The demand for ODTs is increasing across different therapeutic areas, including neurology, psychiatry, and pain management. ODTs offer several advantages over conventional tablets, such as faster onset of action, improved patient compliance, and ease of administration, which are particularly important for treating certain diseases. This will enhance the growth and demand for the superdisintegrants market in the upcoming years.
Industry Dynamics
Growth Drivers
Increasing demand for orally disintegrating tablets (ODTs) is fuelling the market's growth. ODTs are a popular dosage form that dissolves rapidly in the mouth, making them more convenient and easier to take. Superdisintegrants are essential ingredients in the formulation of ODTs, and the increasing demand for ODTs is driving the growth of the superdisintegrants market. The rising prevalence of chronic diseases, such as diabetes, cancer, and cardiovascular disease, drives the demand for new and innovative drug formulations. Superdisintegrants are essential ingredients in many of these formulations, as they help to improve drug absorption and bioavailability. The pharmaceutical industry is growing rapidly, driven by increasing demand for healthcare products and the development of new drugs. Superdisintegrants are widely used in the pharmaceutical industry, and the growth of the sector is driving the growth of the superdisintegrants market.
Report Segmentation
The market is primarily segmented based on product, formulation, therapeutic area and region.
|
By Product |
By Formulation |
By Therapeutic Area |
By Region |
|
|
|
|
To Understand the Scope of this Report: Speak to Analyst
Crospovidone product is expected to witness fastest growth in forecast period
The crospovidone segment is projected to experience the fastest growth in coming years due to the availability of a wide range of grades of Crospovidone, including high-performing grades for ODTs. The growth of the superdisintegrants market is expected to be driven by the increasing demand for fast-dissolving tablets and the development of novel drug-delivery systems. Crospovidone is a critical ingredient in the formulation of fast-dissolving tablets and ODTs, which are gaining popularity due to their ease of administration, improved patient compliance, and faster onset of action. In addition, the growing demand for generic drugs and the increasing prevalence of chronic diseases are expected to drive the demand for super disintegrants such as Crospovidone. Generic medicines are often formulated as fast-dissolving tablets, and super disintegrants are critical for achieving rapid dissolution and absorption of the drug.
Tablets accounted for the largest market share in 2022
The tablets segment held the largest market share in 2022 due to tablets being the most used dosage form in the pharmaceutical industry, and the demand for tablets is expected to continue to grow due to their convenience, portability, and ease of administration. Superdisintegrants are critical ingredients in tablet formulations, as they help to facilitate the disintegration and dissolution of the tablet, allowing for better absorption of the drug by the body. As a result, the tablet segment is driving the growth of the superdisintegrants market. The increasing demand for tablets across different therapeutic areas, combined with the growing popularity of ODTs, is driving the need for super disintegrants in the market.
Gastrointestinal Diseases is expected to hold the significant revenue share during forecast period
Gastrointestinal Diseases are expected to witness significant revenue in coming years owing to a growing incidence of GI disorders. The incidence of gastrointestinal disorders, such as gastroesophageal reflux disease (GERD), inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS), is increasing worldwide. According to the research published by Annals of Esophagus (AOE), around 20% of people globally are thought to be affected with GERD, which has a high incidence in the general population. These disorders often require medication in tablets or capsules, which can be difficult to swallow. Superdisintegrants, including those based on Crospovidone, can help to improve the disintegration and dissolution properties of these dosage forms, making them easier to swallow and improving drug absorption. This will further drive the growth of the market.
North America garnered the largest revenue share in 2022
In 2022, North America held the largest revenue share and was expected to maintain its dominant position over the study period. The super disintegrants market is expected to grow due to technological advancements in drug delivery systems. For instance, Sublingual and buccal drug delivery systems are designed to deliver drugs through the mucosal lining of the mouth. These drug delivery systems offer a faster onset of action and improved bioavailability compared to oral administration. Super disintegrants are used in the formulation of these drug delivery systems to ensure rapid drug disintegration and absorption .
APAC registered a significant growth rate in 2022
In 2022, APAC witnessed a significant growth rate and is projected to maintain its position in the coming years. The growing pharmaceutical industry in developing countries like China is fueling the demand for super disintegrants as manufacturers seek to differentiate themselves, meet the increasing demand for oral solid dosage forms, and develop more effective drug delivery systems. There are 4,500 pharmaceutical firms in China, most of which are major companies. For instance, BeiGene currently operates in China in addition to the U.S., Europe, and Australia, and the company is presently carrying out more than 90 clinical trials for roughly 30 different medications.
Competitive Insight
Some of the major players operating in the global market include BASF, Roquette Freres, Ashland Global, Dow DuPont, DFE Pharma, Asahi Kasei, Merck, Corel Pharma & Avantor Performance.
Recent Developments
- In January 2022, DFE Pharma, an innovative developer of excipients based in Germany, introduced a new maize starch range for its Nutrofeli excipients for its nutraceuticals business.
- In July 2021, SPI Pharma launched UltraBurst, which significantly improves the dissolve time, one of the most important orally disintegrating tablet (ODT) properties. It is a cutting-edge excipient platform for flash ODTs that allows for disintegration in less than 10 seconds.
Superdisintegrants Market Report Scope
|
Report Attributes |
Details |
|
Market size value in 2024 |
USD 470.7 million |
|
Revenue forecast in 2032 |
USD 829.54 million |
|
CAGR |
7.3% from 2024 - 2032 |
|
Base year |
2023 |
|
Historical data |
2019 - 2022 |
|
Forecast period |
2024 - 2032 |
|
Quantitative units |
Revenue in USD billion and CAGR from 2024 to 2032 |
|
Segments covered |
By Product, By Formulation, By Therapeutic Area, By Region |
|
Regional scope |
North America, Europe, Asia Pacific, Latin America; Middle East & Africa |
|
Key companies |
BASF, Ashland Global, Dow DuPont, Roquette Freres, DFE Pharma, JRS PHARMA, Asahi Kasei, Merck, Corel Pharma Chem & Avantor Performance. |
FAQ's
key companies in the Superdisintegrants Market are BASF, Roquette Freres, Ashland Global, Dow DuPont, DFE Pharma, Asahi Kasei, Merck, Corel Pharma & Avantor Performance.
The global superdisintegrants market expected to grow at a CAGR of 7.3% during the forecast period.
The Superdisintegrants Market report covering key segments are product, formulation, therapeutic area and region
key driving factors in Superdisintegrants Market are Growing Adoption of Orally Disintegrating Tablets.
Superdisintegrants Market Size Worth $ 829.54 Million By 2032.
© 2024 Polaris Market Research and Consulting. All rights reserved
